GlassScriptPhysician profile
Sheryl L Young
NPI 1962401232
$8,765.87
in general payments reported to CMS, 2019-2025
25 companies · $2,024 in 2025
The $2,024 reported for 2025 was more than what 84% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $1,303 · 2021: $855 · 2022: $1,946 · 2023: $1,247 · 2024: $454 · 2025: $2,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,920 · Travel and Lodging: $719 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,920.03 |
| Travel and Lodging | $719.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,452.82 | 2019-2025 | |
| Motiva USA, LLC | $1,714.33 | 2025 | |
| Mentor Worldwide LLC | $1,393.25 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Allergan, INC. | $544.79 | 2019-2022 | |
| Sientra, INC. | $371.70 | 2019-2022 | |
| Tepha INC | $369.23 | 2019 | |
| Galderma Laboratories, L.P. | $352.25 | 2020-2025 | Dysport |
| Abbvie INC. | $321.58 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $251.90 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Axogen | $183.59 | 2023 | Avance Nerve Graft |
| Davol INC. | $163.65 | 2022 | |
| Kerecis Limited | $103.32 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Acelrx Pharmaceuticals, INC. | $99.53 | 2021-2022 | |
| Organogenesis INC. | $74.29 | 2021 | |
| Tela Bio, INC. | $62.10 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $61.19 | 2020-2024 | Exparel |
| Kowa Pharmaceuticals America, INC. | $49.39 | 2023 | Seglentis |
| Acera Surgical, INC. | $42.62 | 2023 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $31.68 | 2025 | Matriderm |
| Endo Pharmaceuticals INC. | $31.62 | 2022-2023 | Xiaflex |
| Medtronic USA, INC. | $23.74 | 2019 | |
| Polynovo North America LLC | $21.05 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $18.53 | 2025 | |
| Vertical Pharmaceuticals, LLC | $15.72 | 2023 | Dsuvia |
| Apyx Medical Corporation | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.